高警訊藥品 |
|||
|---|---|---|---|
|
當一個藥品使用錯誤時，有極高機率會對病人造成明顯傷害，則稱此藥為高警訊藥品 ( high-alert medications )。本部比照美國ISMP ( Institute for Safe Medication Practices ) 公佈之高警訊藥品訂定本院之高警訊藥品品項，定期更新公告，提供全院醫療人員參考。 |
|||
|
表. 美國ISMP定義高警訊藥品 |
|||
|
應提高警覺之22類藥品 |
應提高警覺之12項特定藥品 |
||
|
1. |
Adrenergic agonists, iv |
1. |
EPINEPHrine |
|
2. |
Adrenergic antagonists, iv |
2. |
Subcutaneous epoprostenol (Flolan),IV
|
|
3. |
Anesthetic agents, general, inhaled & iv |
3. |
Insulin U-500 (special emphasis) |
|
4. |
Antiarrhythmics, iv |
4. |
Magnesium sulfate injection |
|
5. |
Antithrombotic agents, including warfarin, |
5. |
Methotrexate, oral, non-oncologic use |
|
low-molecular-weight heparin, iv |
6. |
Opium tincture | |
|
unfractionated heparin, factor Xa |
7. |
Oxytocin, IV | |
|
inhibitors, direct thrombin inhibitors, |
8. |
Nitroprusside, sodium, for injection | |
|
thrombolytics, and glycoprotein IIb/IIIa |
9. |
Potassium chloride for injection | |
|
inhibitors |
10. |
Concentrate potassium phosphates injection | |
|
6. |
Cardioplegic solutions |
11. | Promethazine, IV |
|
7. |
Chemotherapeutic agents, parenteral & oral |
12. | Vasopressin, IV or intraosseous |
|
8. |
Dextrose, hypertonic, 20% or greater |
||
|
9. |
Dialysis solutions, peritoneal & hemodialysis |
||
|
10. |
Epidural or intrathecal medications |
|
|
|
11. |
Hypoglycemics, oral |
||
|
12. |
Inotropic medications, iv |
||
|
13. |
Insulin, subcutaneous and IV |
||
|
14. |
Liposomal forms of drugs (e.g., liposomal amphotericin B) |
||
|
15. |
Moderate sedation agents, IV |
||
| 16. | Moderate sedation agents, oral, for children | ||
|
17. |
Narcotics/opiates, iv , transdermal & oral |
||
|
(including liquid concentrates, immediate- & |
|||
|
sustained- release) |
|||
|
18. |
Neuromuscular blocking agents |
||
|
19. |
Parenteral nutrition preparations |
||
|
20. |
Radiocontrast agents, IV |
||
|
21. |
Sterile water for injection, inhalation, and irrigation (excluding pour bottles) in containers of 100ml or more |
||
|
22. |
Sodium chloride injection, hypertonic, more than 0.9% concentration |
||